Sayak Banerjee, Amity University Kolkata
The toxin of the cone-like ocean snail (Conus nux) was used to manufacture medicines against intense fever and forms of infections in step with research from the Florida Atlantic University (FAU) School of Medication. The researchers as a team started from the likelihood that non-stick medications could be the way for betterment. They found that some intestinal sicknesses such as Plasmodium falciparum can be fatal even after therapy with existing medications.
This is due to the firm “cyto-grip” of the infected erythrocytes despite the parasites staying dead within the platelets. The research gives noteworthy insights towards the progression of a novel and practical adversary of adherent or inhibiting treatment drugs focused on inspecting the pathology of tremendous intestinal sickness. The scientists used instances of Conus nux gathered from the Pacific shore of Costa Rica in their tests. The tests exposed the “in vitro” capacity of cone snail toxin to interfere with protein-protein and protein-polysaccharide interactions that add to the pathology of Plasmodium falciparum intestinal sickness.
By revealing their ability to interfere with protein-protein and protein-polysaccharide interactions that easily add to illness, the research widens the pharmacological scope of conotoxins or mono peptides present in the toxin of the snail Conus nux. Conotoxins could be employed as probable inhibitors of protein-protein interactions as a treatment for illnesses like AIDS and COVID-19. One of the scientists stated that sub-atomic reliability, small size, solvency, intravenous network, and absence of immunogenic reaction make conotoxins an outstanding contender for inhibiting treatment. Conotoxins have been broadly analyzed for fairly a long time as sub-atomic tests and medication guides targeted on the focal sensory system.
More research is required for novel applications focused on impeding imprudent cell reactions or obstructing host-parasite associations through its restraining with endogenous and exogenous proteins. The interference of protein-protein interactions by conotoxins is an extension of their known inhibitory action on numerous particle channels and receptors. Among over 850 types of cone snails, there are uncountable diverse harmful exopeptidases that have been chosen more than a few million years of growth to seize prey and avert hunters.
Also read:Priority Review for Pfizer’s tick-borne encephalitis vaccine in the US
Source:
Alberto Padilla, Sanaz Dovell, Olga Chesnokov, Mickelene Hoggard, Andrew V. Oleinikov, Frank Marí. Conus venom fractions inhibit the adhesion of Plasmodium falciparum erythrocyte membrane protein 1 domains to the host vascular receptors. Journal of Proteomics, 2021; 234: 104083 DOI: 10.1016/j.jprot.2020.104083
https://philsportsnews.com/the-venom-of-a-sea-snail-can-help-treat-malaria/
- The Corrosion Prediction from the Corrosion Product Performance
- Nitrogen Resilience in Waterlogged Soybean plants
- Cell Senescence in Type II Diabetes: Therapeutic Potential
- Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP
- AI Literacy in Early Childhood Education: Challenges and Opportunities
One thought on “Sea Snail Venom can help to cure Malaria”